Pinned Tweet
Slowing ageing and increasing health-span with anti-IL11 therapy
A 20 min video m.youtube.com/watch?v=oNc5Mx…
Met an “I’m a biotech” guy today. Introduced himself as a ‘serial C-suite’ chap. I thought, what a complete zero-value-add arse. And he was. They mostly are.
2
4
1,077
Therapeutic (small molecule) inhibition of global gp130 signaling improves right ventricular function in a pig model of RV loading.
PAH in humans next?
🙌 scholar.google.com.sg/schola…
7
1,379
Wonderful leaving dinner with Imperial friends and colleagues last night. Thank you for the kind words and the lovely present, which will be put to very good use! 🤗
Now perhaps the most replicated target gene for lung fibrosis in multiple POC studies
Four clinical trials in progress:
NCT05331300
NCT05658107
NCT05740475
NCT06612970
All began with PMID: 31554736, just 6 years ago
🚀 pubmed.ncbi.nlm.nih.gov/3979…
Bi-specific
Anti-IL11 + Anti-TSLP
Perhaps for asthma?
Field moving fast clinicaltrials.gov/study/NCT…
1
12
1,083
Clever - non-antibody - ways to inhibit IL11 activity using biased agonist-like modalities to treat fibrotic lung disease:
sciencedirect.com/science/ar…
And
sciencedirect.com/science/ar…
10
1,058
Nice
As predicted:
pubmed.ncbi.nlm.nih.gov/3662…
We are happy to share our new paper. We identified il11 as a regenerative factor to stimulate heart regeneration. However, prolonged il11 treatment causes fibrosis due to persistent activation of the epicardium.
nature.com/articles/s41467-0…
16
1,603
🙌
IL11 is directly toxic in cardiac myocytes causing calcium handling disturbance and impaired contraction
Negatively inotropic in vivo
Not just a fibroblast factor
Heart failure target?
🤨
academic.oup.com/cardiovascr…
Timely reminder that the IL-6 (IL-11) trans-signalling idea/field is likely based on an experimental artefact
pubmed.ncbi.nlm.nih.gov/3833…
8
869
Pssst - its not just IL11 effects on fibroblasts:
“These data show that IL11 inhibits reparative AT2-to-AT1 differentiation in the damaged lung to limit endogenous alveolar regeneration, resulting in fibrotic lung disease”
Damaging EMT, as seen in kidney nature.com/articles/s41467-0…
Nice.
Check out the GWAS hits for menopause at the IL11 locus…
Coincidence?
Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse
link.springer.com/article/10…
Trametinib common side effects (BNF):
Abdominal pain; anaemia; constipation; cough; dehydration; diarrhoea; dry mouth; fever; haemorrhage; hypersensitivity; infection; intracranial haemorrhage; lymphoedema; nausea; dyspnea; stomatitis; vomiting, etc biorxiv.org/content/10.1101/…
3
4
1,420
💯
We wanted to keep in the clock data, even if pushed to the supplement. We appealed to both the reviewer and [separately] the editor.
If something is truly ‘anti-ageing’ it should affect epigenetic clock, across tissues.
I think it should be a standard biomarker.
Sometimes peer review diminishes the quality of an article. Painful example: the authors had to remove their striking epigenetic clock results from the high profile paper titled "Inhibition of IL-11 Signaling Extends Mammalian Healthspan and Lifespan." Fortunately, the peer review files are available online.
rdcu.be/dPaL5
Stuart Cook retweeted
Replying to @ImmunoFever @stuartacook1 @MartinBJensen @aa_widjaja @metapredict @MitoPsychoBio @KSadtler
And to keep these thoughts in one🧵: I really think this exciting new understanding of the impacts of IL-11 signaling will help us better understand how Th2-type responses could drive #IACI. There's much metabolic overlap between these illnesses and aging.
ncbi.nlm.nih.gov/pmc/article…
It is suggested we do more [5 year] mice studies but how about a human trial?
We have an anti-IL11 therapy specifically engineered for human ageing trials at vvb.bio.
Needs investment, build out, approvable endpoints and not easy +++. But faster to humans…
I’ll raise you: How about a clinical trial?
We have engineered a super long acting and potent anti-IL11 for human ageing trials at vvb.bio/.
Faster to humans, not another 5 years in mice
Needs investment, build out, approvable endpoints and not easy ++. But..
A very interesting question. My best guess = nerves.
In old IL11-EGFP mice there is big signal in skeletal muscle nerve bundles/NMJ (see Supl figs).
Recovery of function with anti-IL11 is > muscle mass effect. So I think innervation is important….
Replying to @metapredict @stuartacook1
Any thoughts on the muscle mechanism? I can see from our large human data sets that the most variable IL11RA transcript is the low abundance 390aa variant, with the high signal variant (422aa) largely invariant.
We did epigenetic clock in the mice. Large effect (++). Reviewer 1 made us take it out (despite our protests - see rebuttal at Nature website). Data is shown in our online talks and on BioRxiv (I think). For sure a biomarker of interest for human trials…
IL11 upregulates PDL1 to promote tumour immune escape
There will be a lot more coming on this
Already heading to clinical trials with Mabwell Therapeutics:
aacrjournals.org/cancerres/a… onlinelibrary.wiley.com/doi/…










